Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma-Reference-Cited by-同舟云学术

Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma

Published:2006-03 Issue:3 Volume:17 Page:450-456
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Folprecht G.,Lutz M.P.,Schöffski P.,Seufferlein T.,Nolting A.,Pollert P.,Köhne C.-H.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/17/3/450/340693/mdj084.pdf

Reference30 articles.

1. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer;de Gramont;J Clin Oncol,2000

2. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer;Giacchetti;J Clin Oncol,2000

3. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial;Douillard;Lancet,2000

4. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer;Saltz;Irinotecan Study Group. N Engl J Med,2000

5. Phase III study of bolus 5-fluorouracil (5-FU)/ folinic acid (FA) (Mayo) vs weekly high-dose 24h 5-FU infusion/ FA + oxaliplatin (OXA) (FUFOX) in advanced colorectal cancer (ACRC);Grothey;Proc Am Soc Clin Oncol,2002

Cited by 211 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse effects of anti-cancer biologics on the ocular surface;Current Opinion in Allergy & Clinical Immunology;2024-07-04

2. Therapeutic drug monitoring of selected anticancer drugs;Therapeutic Drug Monitoring;2024

3. Therapie von Lebermetastasen;Die Onkologie;2023-01-31

4. A systematic analysis in efficacy and safety of nimotuzumab combined with chemoradiotherapy in treatment of advanced nasopharyngeal carcinoma;European Archives of Oto-Rhino-Laryngology;2022-09-02

5. Efficacy and Safety of Cetuximab Dosing (biweekly vs weekly) in Patients with KRAS Wild-type Metastatic Colorectal Cancer: A Meta-analysis;The Oncologist;2022-02-19